Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

F Rousset, Elisabeth Garcia, Thierry Defrance, +6

Proceedings of the National Academy of Sciences

Lymphocyte DevelopmentHumoral ResponseImmunologyImmune RegulationImmunologic Mechanism +18

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

Michael A. Morse, Jennifer Garst, Takuya Osada, +10

Journal of Translational Medicine

Production and characterization of clinical grade exosomes derived from dendritic cells

Henry Lamparski, Anita Metha-Damani, Jenq-Yuan Yao, +4

Journal of Immunological Methods

Extracellular VesiclesClinical Grade ExosomesMedicineImmunologyPathology +8

Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1

Di‐Hwei Hsu, René de Waal Malefyt, David Fiorentino, +6

Science

Epstein-barr Virus Bcrf1CytokineRecombinant Bcrf1 ProteinAutoimmune DiseaseAdaptive Immune System +13

Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

Fabrice André, Nathalie Chaput, Noël E.C. Schartz, +11

The Journal of Immunology

ImmunologyCurrent Immunization ProtocolsImmunodominanceAntigen ProcessingImmune Cell Therapy +18

A receptor for interleukin 10 is related to interferon receptors.

A S Ho, Y Liu, T. A. Khan, +3

Proceedings of the National Academy of Sciences

Mouse Mast CellImmunologyImmune RegulationImmunologic MechanismInnate Immunity +14

Exosomes as a Tumor Vaccine: Enhancing Potency Through Direct Loading of Antigenic Peptides

Di‐Hwei Hsu, Pedro Paz, Gilbert Villaflor, +5

Journal of Immunotherapy

Antigenic PeptidesImmunologyImmunologic MechanismExtracellular MicrovesiclesAntigen Processing +16

HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IS IMMUNOSUPPRESSIVE TO T CELLS WHILE EXHIBITING REDUCED MITOGENICITY IN VITRO1

Michael S. Cole, Karl E. Stellrecht, Jia Shi, +5

Transplantation

A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex‐specific monoclonal antibody

Susan Eastman, Michael Deftos, Paul deRoos, +5

European Journal of Immunology

A HUMANIZED ANTI-CD3 ANTIBODY, HuM291, WITH LOW MITOGENIC ACTIVITY, MEDIATES COMPLETE AND REVERSIBLE T-CELL DEPLETION IN CHIMPANZEES

Di‐Hwei Hsu, Jia Shi, Margit Homola, +7

Transplantation